$2.38
5.78% yesterday
Nasdaq, Aug 21, 10:00 pm CET
ISIN
US81749D1072
Symbol
SERA

Sera Prognostics Inc - Ordinary Shares Class A Stock price

$2.38
-0.54 18.49% 1M
-1.74 42.23% 6M
-5.76 70.76% YTD
-4.82 66.94% 1Y
+0.28 13.33% 3Y
-9.52 80.00% 5Y
-9.52 80.00% 10Y
-9.52 80.00% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
+0.13 5.78%
ISIN
US81749D1072
Symbol
SERA
Industry

Key metrics

Basic
Market capitalization
$85.6m
Enterprise Value
$45.5m
Net debt
positive
Cash
$40.2m
Shares outstanding
38.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
778.5 | 226.9
EV/Sales
413.6 | 120.6
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
65.9%
Return on Equity
-68.8%
ROCE
-41.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$110.0k | $377.4k
EBITDA
$-36.0m | $-34.2m
EBIT
$-36.9m | $-41.1m
Net Income
$-32.7m | $-34.5m
Free Cash Flow
$-27.0m
Growth (TTM | estimate)
Revenue
0.0% | 371.8%
EBITDA
-4.2% | 4.6%
EBIT
-4.2% | -12.2%
Net Income
-3.8% | -4.9%
Free Cash Flow
-67.9%
Margin (TTM | estimate)
Gross
-16.7%
EBITDA
-33,323.2% | -9,054.1%
EBIT
-34,125.0%
Net
-30,306.5% | -9,147.8%
Free Cash Flow
-24,953.7%
More
EPS
$-0.7
FCF per Share
$-0.7
Short interest
4.2%
Employees
64
Rev per Employee
$0.0
Show more

Is Sera Prognostics Inc - Ordinary Shares Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,014 stocks worldwide.

Sera Prognostics Inc - Ordinary Shares Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Sera Prognostics Inc - Ordinary Shares Class A forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Sera Prognostics Inc - Ordinary Shares Class A forecast:

Buy
88%
Hold
13%

Financial data from Sera Prognostics Inc - Ordinary Shares Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.11 0.11
0% 0%
100%
- Direct Costs 0.13 0.13
30% 30%
118%
-0.02 -0.02
-
-18%
- Selling and Administrative Expenses 24 24
18% 18%
21,391%
- Research and Development Expense 13 13
14% 14%
12,100%
-36 -36
4% 4%
-32,718%
- Depreciation and Amortization 0.87 0.87
2% 2%
791%
EBIT (Operating Income) EBIT -37 -37
4% 4%
-33,505%
Net Profit -33 -33
4% 4%
-29,755%

In millions USD.

Don't miss a Thing! We will send you all news about Sera Prognostics Inc - Ordinary Shares Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sera Prognostics Inc - Ordinary Shares Class A Stock News

Neutral
Seeking Alpha
15 days ago
Sera Prognostics, Inc. (NASDAQ:SERA ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Austin Aerts - Chief Financial Officer Evguenia Lindgardt - President, CEO & Director Conference Call Participants Margarate Elizabeth Boeye - William Blair & Company L.L.C., Research Division William Ruby - TD Cowen, Research Division Peter DeNardo - Unidentified Company Operat...
Positive
The Motley Fool
15 days ago
Sera Prognostics (SERA 12.24%), a diagnostic company specializing in pregnancy risk prediction, reported Q2 2025 results on August 6, 2025. The company's headline news was a net loss improvement and continued strategic investment toward commercial rollout, despite revenue remaining extremely modest.
Neutral
PRNewsWire
15 days ago
SALT LAKE CITY , Aug. 6, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter of 2025 ended June 30, 2025. Second Quarter and Recent Highlights: Ongoing progress in engaging Medic...
More Sera Prognostics Inc - Ordinary Shares Class A News

Company Profile

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Evguenia Lindgardt
Employees 64
Founded 2008
Website www.seraprognostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today